TTAB Oppositions 91268891
USPTO Oppositions proceeding 91268891, filed 2021-04-21. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91268891 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2021-04-21 |
| Last Activity | 2021-08-03 |
| Days Active | 1850 |
Parties
- GL Biotech Inc. — Defendant
- Iovance Biotherapeutics, Inc. — Plaintiff
Plaintiff Marks
- IOVANCE — Iovance Biotherapeutics, Inc.
- IOVANCE — Iovance Biotherapeutics, Inc.
- IOVANCE BIOTHERAPEUTICS — Iovance Biotherapeutics, Inc.
- IOVANCE BIOTHERAPEUTICS — Iovance Biotherapeutics, Inc.
- IOVANCE BIOTHERAPEUTICS — Iovance Biotherapeutics, Inc.
- IOVANCE BIOTHERAPEUTICS — Iovance Biotherapeutics, Inc.
- IOVANCE BIOTHERAPEUTICS — Iovance Biotherapeutics, Inc.
- IOVANCE BIOTHERAPEUTICS — Iovance Biotherapeutics, Inc.
- IOVANCE BIOTHERAPEUTICS — Iovance Biotherapeutics, Inc.
- IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY — Iovance Biotherapeutics, Inc.
- IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY — Iovance Biotherapeutics, Inc.
- IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY — Iovance Biotherapeutics, Inc.
- IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY — Iovance Biotherapeutics, Inc.
- IOVANCECARES — Iovance Biotherapeutics, Inc.
- IOVANCECARES — Iovance Biotherapeutics, Inc.
Defendant Marks
- INNOVANCE — GL Biotech Inc.
Recent Documents
- 2021-08-03: TERMINATED — Status
- 2021-08-03: BD DECISION: OPP SUSTAINED — Decisions
- 2021-06-11: NOTICE OF DEFAULT — Defaults
- 2021-04-21: INSTITUTED — Status
- 2021-04-21: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2021-04-21: FILED AND FEE — Fees